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Abstract
Background: Anthrax and plague are diseases caused by Bacillus anthracis and Yersinia pestis
respectively. These bacteria are etiological agents for worldwide zoonotic diseases and are
considered among the most feared potential bioterror agents. Strain differentiation is difficult for
these microorganisms because of their high intraspecies genome homogeneity. Moreover, fast
strain identification and comparison with known genotypes may be crucial for naturally occurring
outbreaks versus bioterrorist events discrimination.
Results: Thirty-nine B. anthracis and ten Y. pestis strains, representative of the species genetic
diversity, were genotyped by Agilent 2100 Bioanalyzer using previously described Multiple Locus
VNTR Analysis assays (MLVA). Results were compared to previous data obtained by standard
genotyping system (capillary electrophoresis on automatic sequencer) and, when necessary, direct
amplicon sequencing. A reference comparison table containing actual fragment sizes, sequencer
sizes and Agilent sizes was produced.
Conclusion: In this report an automated DNA electrophoresis apparatus which provides a
cheaper alternative compared to capillary electrophoresis approaches was applied for genotyping
of B. anthracis and Y. pestis. This equipment, uses pre-cast gels and provides easy transportation,
low maintenance and overall general logistic requirements and costs, is easy to set up and provides
rapid analysis. This platform is a candidate for on-site MLVA genotyping of biothreat agents as well
as other bacterial pathogens. It is an alternative to the more expensive and demanding capillary
electrophoresis methods, and to the less expensive but more time-consuming classical gel
electrophoresis approach.
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Bacillus anthracis is a Gram-positive spore-forming bacil-
lus that causes anthrax [1,2]. This bacterium is commonly
found in soil and is responsible for diseases of herbivores
and other mammals including humans. Anthrax is still
endemic in many countries, Middle East, Africa, North,
Central and South America, as well as other areas of the
world [3]. The site of entry determines different forms of
anthrax, cutaneous, gastrointestinal, and inhalation; the
latter form is highly fatal, with a mortality rate of up to
80% in the absence of an adequate antimicrobial therapy.
Yersinia pestis is a Gram-negative bacterium, etiological
agent of plague. The bacterium is transmitted by fleas or
aerosols, causing different forms of plague: bubonic, sep-
ticemic or pneumonic [4,5]. Y.pestis is often associated
with the wellknown Black Death plague of the Middle
Ages, a pandemic that had killed a third of European pop-
ulation in the 14th and 15th centuries, but approximately
2,000 human cases still occur worldwide each year [5].
Primary pneumonic plague is rapidly progressive and vir-
ulent, and, as inhalation anthrax, with a mortality rate
close to 100% in the absence of a timely treatment. Y. pes-
tis and B. anthracis are both considered serious threats and
potential bioterrorism agents [6] because of their evalua-
tion as bioweapons by Soviet Union and United States
laboratories during the past decades. Above all, B. anthra-
cis gained renewed attention in 2001, when letters con-
taining anthrax spores were mailed causing the death of
five persons and infecting 17 others, while probably hun-
dreds of people were exposed to infectious spores [7].
Both agents are classified by the US Centre for Disease
Control and Prevention in the Bioterrorism Disease Agent
List as Category A microrganism, the most dangerous
ones, because of easy dissemination and transmission,
high mortality and impact to public health.
B. anthracis and Y. pestis both show very low intraspecies
genetic diversity [8-10], making very challenging the rapid
and accurate differentiation among individual biovars
and strains. Nevertheless, finding a way to differenziate
the strains by molecular genotyping, remains essential for
discrimination between naturally occurring versus inten-
tional outbreaks. The importance of forensic microbiol-
ogy, as this field is know called, was demonstrated during
the 2001 events, and previously by Tokyo [11] and Sverd-
lovsk [12] incidents. Finally genetic characterization of
isolates allows to increase information about worldwide
bacterial distribution and epidemiology.
Standard genotyping methods require either highly dis-
criminative but heavy, and relatively expensive devices
such as automated capillary electrophoresis devices, or
cheaper, easy to use but more time consuming and with
lower resolution power such as agarose gels (for a review
of bacterial MLVA genotyping see [13]). A new miniatur-
ized platform for quantification and separation of nucleic
acid molecules, Agilent 2100 Bioanalyzer, has shown
accuracy, precision and high feasibility along with speed
and moderate cost reagents. This platform is based on
microfluidic technology and allows to analyze 12 DNA
samples in 30 minutes. The device, also called "Lab on a
Chip", integrates multiple functions onto a single appara-
tus, so that sample dispensing, separation, detection and
analysis are performed on the same support (a 5 × 5 cm
chipper-cast gel). Along with limited weight and size (10
kg, 162 × 412 × 290 mm), the above features make the
instrument ideal for field use and other on-site investiga-
tions. Agilent 2100 can also be easily used by low-exper-
tise staff. A similar system was previously employed to
study the genetic variability of bclA gene for strain discrim-
ination within the Bacillus cereus group [14]. In this paper
we evaluate this approach for genotyping analysis of the
two major biothreat agents.
Results
Experimental design
In order to validate this platform, we compared the data
produced by the Agilent 2100 Bioanalyzer to agarose gel
based data (B. anthracis, Y. pestis) and capillary gel based
data (B. anthracis). Ten Y. pestis and thirty-nine B. anthracis
strains were genotyped using previously described sets of
25 VNTR loci [15,16]. These previously genotyped strains
[15,16] were chosen to be representative of allelic variabil-
ity within the two species. Briefly, these genotypes are
from strains with the largest genetic distance, encompass-
ing most of the observed allele variation (fig. 1 and 2). The
25 VNTR markers amplified for bacterial genotyping, were
arranged into 12 PCR multiplex reactions either for B.
anthracis or Y. pestis. This allowed us to use a single DNA
1000 chip for each strain.
After PCR amplification 1 µl of each reaction was loaded
into 12-wells chip (DNA 1000 LabChip Kit). Primer con-
centrations were experimentally adjusted to obtain a bal-
anced amplification of different fragments. This
optimization was facilitated using the quantification data
supplied by the 2100 Bioanalyzer (peak area and fluores-
cence peak level). The vast majority of data produced by
Agilent 2100 were not accurate. The discrepancies
between observed and expected fragment size (offset in
Table 1 and 2) are, presumably, the result of abnormal
migration patterns of some repetitive sequences into elec-
trophoretic matrix. In order to check if the offset was
reproducible, we tested interchip and intrachip variability
in markers containing the smallest repeat units, for which
incorrect allelic calling is more probable. The samples
were run in triplicate on the same and on different chips,
and size data compared. In general, it was observed a low
level of inter-intrachip variability (less than 25 % of thePage 2 of 11
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BMC Microbiology 2008, 8:21 http://www.biomedcentral.com/1471-2180/8/21repeat unit length). For example, for B. anthracis CG3
marker (UL = 5, so 25% UL = 1,25), we observed 168 ± 1
for allele 1 and 173 ± 1 for allele 2. To correctly convert
the Agilent DNA fragment size estimates into repeat copy
numbers, it was necessary to establish conversion tables
(Table 1 and 2) containing 2100 Bioanalyzer fragment
sizes as well as actual sizes corresponding to repeats unit
numbers, as previously reported [16].
Once these reproducible offset values are taken into
account, the MLVA assay as run on the Agilent exhibited
concordant results with previous typing results for B.
UPGMA dendrogram showing clustering and linkage distances of B. anthracis strains used to validate the Bioanalyzer 25 MLVA genotypingFigure 1
UPGMA dendrogram showing clustering and linkage distances of B. anthracis strains used to validate the Bioanalyzer 25 MLVA 
genotyping. The results obtained by previously described method [16] and Bioanalyzer genotyping are identical.Page 3 of 11
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closely sized DNA fragments, and the analyzed samples
showed concordance either with interchip repetitions or
with expected size data. These data, used for UPGMA clus-
ter analysis, generate dendrograms with linkage distance
perfectly identical to those previously obtained by stand-
ard methodologies (Fig. 1 and 2). For each individual
strain the Agilent assay is completed in about 30 minutes
after PCR amplification. For a single strain to be geno-
typed, this time is significantly lower than 3 hours
described in previous assay [16].
Genotyping B. anthracis with the 25-loci MLVA
To fit all the 25 loci into a 12-wells chip the B. anthracis
loci were combined into 5 triplex, 3 duplex and 4 single-
plex (Table 1) PCR amplifications. The arrangement of
different loci in the same multiplex is such as to avoid
overlapping of VNTR markers size ranges. For four B.
anthracis loci multiplexing was impossible, because of the
large allele size range.
Primer sequences were as described in [16], loci combina-
tion and final primers concentrations are reported in
Table 1. Under these conditions, we were able to amplify
each expected fragment, and the software (Agilent 2100
Expert version B.02.03.SI307, firmware C.01.055) could
identify amplicon size (Fig. 3). The offset values for all loci
and alleles were measured and are presented in Tables 1
and 2. For chromosomal markers, reproducibility of the
observed data allowed correct assignment of each allele
for every locus (<25% of unit length). However, for plas-
mid markers, since their shorter repeat unit and PCR
product size compared to the chromosomal ones, we
observed variability not exceeding one single additional
base for each allele in repeated runs. Even with this addi-
tional base, correct assignment could be reproducibly
done for the plasmid loci.
Genotyping Y. pestis with the 25-loci MLVA
To fit all the 25 loci into 12 chip wells the Y. pestis 25
markers were grouped into 11 duplex and one triplex
(Table 2).
The majority of primer sequences were as described in
[15] but for 8 Y. pestis markers new primer pairs were rede-
signed to allow multiplexing (Table 3). Thus, final ampli-
con size was increased to avoid any possible overlap with
other different loci into the new multiplexed reactions
(Fig. 4). For Y. pestis markers (for which repeat units are at
least 7 bp long [15,17]), we observed variability up to two
bases (at the shortest repeat units) and, as previously
described for B. anthracis, discrepancies not exceeding
25% of the repeat unit size.
UPGMA dendrogram showing clustering and linkage distances of Y. pestis strains used to validate Agilent Bioanalyzer 2100 based genotypinFigure 2
UPGMA dendrogram showing clustering and linkage distances of Y. pestis strains used to validate Agilent Bioanalyzer 2100 
based genotyping. The results obtained by previously described method [15] and Bioanalyzer genotyping are identical.Page 4 of 11
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BMC Microbiology 2008, 8:21 http://www.biomedcentral.com/1471-2180/8/21Table 1: Comparison between B. anthracis product sizes inferred by Agilent 2100 Bioanalyzer software (OBSERVED SIZE) and actual 
sizes obtained by direct sequencing of the PCR product or data available in Genbank (EXPECTED SIZE). UL BPS (unit length size).
MULTIPLEX MARKER (final primer 
concentration, µM) UL BPS ALLELE EXPECTED SIZE OBSERVED SIZE OFFSET
1 CG3 (1.1) 5 1 153 168 -15
2 158 173 -15
BAMS44 (0.8) 39 6 339 350 -11
8 417 431 -14
BAMS3 (0.6) 15 21 474 455 19
24 519 499 20
26 549 529 20
27 564 546 18
28 579 562 17
30 609 586 23
2 vrrB2 (0.15) 9 4 135 141 -6
6 153 159 -6
7 162 168 -6
8 171 177 -6
BAMS5 (0.28) 39 3 229 230 -1
5 307 297 10
6 346 333 13
7 385 370 15
8 424 411 13
BAMS15 (0.6) 9 24 418 427 -9
27 445 448 -3
41 571 581 -10
42 580 595 -15
44 598 613 -15
45 607 619 -12
46 616 624 -8
3 BAMS1 (0.6) 21 11 380 353 27
12 401 371 30
13 422 387 35
14 443 404 39
16 485 444 41
vrrC1 (0.28) 9 46 517 501 16
48 535 520 15
53 583 564 19
57 616 595 21
4 BAMS13 (0.28) 9 17 337 334 3
20 364 362 2
21 373 370 3
24 391 386 5
27 427 421 6
30 454 452 2
31 463 459 4
47 607 597 10
76 868 807 61
5 vrrB1 (0.15) 9 12 193 198 -5
15 220 229 -9
16 229 237 -8
19 256 264 -8
BAMS28 (0.6) 24 10 397 394 3
13 469 468 1
14 493 492 1
vrrC2 (0.6) 18 17 532 515 17
19 568 549 19
21 604 583 21Page 5 of 11
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8 236 249 -13
BAMS31 (0.6) 9 15 331 332 -1
49 637 638 -1
55 691 674 17
56 700 681 19
57 709 684 25
64 772 733 39
65 781 742 39
84 952 935 17
7 vrrA (0.1) 12 8 290 293 -3
9 302 305 -3
10 314 320 -6
11 326 333 -7
BAMS25 (1.1) 15 12 376 370 6
13 391 381 10
BAMS21 (1.1) 45 9 631 599 32
10 676 629 47
8 BAMS34 (0.4) 39 8 425 399 26
9 503 477 26
11 581 550 31
9 BAMS24 (0.4) 42 9 511 526 -15
10 553 571 -18
11 595 608 -13
10 pXO1 (0.6) 3 6 123 135 -12
7 126 138 -12
8 129 141 -12
9 132 145 -13
BAMS51 (0.4) 45 6 358 338 20
8 448 414 34
9 493 468 25
10 538 508 30
BAMS22 (0.4) 36 11 555 527 28
13 627 581 46
14 663 624 39
15 699 643 56
16 735 659 76
11 BAMS23 (1.1) 42 5 399 377 22
9 567 518 49
10 609 557 52
11 651 572 79
pXO2 (0.28) 2 6 135 165 -30
7 137 168 -31
8 139 170 -31
9 141 172 -31
12 BAMS30 (0.8) 9 6 268 269 -1
17 367 360 7
51 673 670 3
57 727 685 42
60 754 700 54
68 826 770 56
69 835 776 59
72 862 796 66
75 889 817 72
78 916 840 76
Table 1: Comparison between B. anthracis product sizes inferred by Agilent 2100 Bioanalyzer software (OBSERVED SIZE) and actual 
sizes obtained by direct sequencing of the PCR product or data available in Genbank (EXPECTED SIZE). UL BPS (unit length size). Page 6 of 11
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BMC Microbiology 2008, 8:21 http://www.biomedcentral.com/1471-2180/8/21Table 2: Comparison between Y. pestis product sizes inferred by Agilent 2100 Bioanalyzer software (OBSERVED SIZE) and actual sizes 
obtained by direct sequencing of the PCR product or data available in Genbank (EXPECTED SIZE). UL BPS (unit length size).
MULTIPLEX MARKER (final primer 
concentration, µM)
UL BPS ALLELE EXPECTED SIZE OBSERVED SIZE OFFSET
1 ypms51 (0.2) 21 1 186 185 1
2 207 207 0
ypms01* (0.2) 18 6 283 279 4
7 301 291 10
9 337 329 8
10 355 344 11
2 ypms04 (0.2) 17 5 179 187 -8
6 196 205 -9
8 230 241 -11
9 247 259 -12
ypms62* (0.2) 9 5 270 258 12
6 279 267 12
9 306 285 21
10 315 294 21
12 333 308 25
15 360 331 29
20 405 366 39
3 ypms07 (0.2) 10 7 164 168 -4
8 174 178 -4
9 184 187 -3
ypms05 (0.2) 17 10 274 285 -11
11 291 300 -9
4 ypms74 (0.2) 15 5 180 178 2
6 195 190 5
7 210 203 7
8 225 217 8
ypms15* (0.2) 15 9 275 272 3
10 290 284 6
5 ypms35 (0.2) 15 8 204 208 -4
9 219 222 -3
ypms40* (0.2) 17 7 253 252 1
8 270 266 4
9 287 277 10
6 ypms38 (0.2) 16 6 201 200 1
7 217 215 2
8 233 230 3
ypms20* (0.2) 15 8 288 285 3
9 303 300 3
7 ypms41 (0.2) 17 5 183 188 -5
6 200 207 -7
7 217 221 -4
ypms56* (0.2) 16 7 258 265 -7
9 290 296 -6
8 ypms45 (0.2) 12 6 149 147 2
7 161 159 2
ypms44 (0.2) 17 7 233 239 -6
8 250 260 -10
ypms09* (0.2) 18 22 732 671 61
32 930 847 83Page 7 of 11
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The intentional release of anthrax spores by mail in 2001
in the United States caused the death of five persons by
inhalation anthrax and publicly demonstrated the bio-
weapon-associated threat, of which only the community
of biodefence experts was previously aware. This increased
the demands for a better genetic characterization of bio-
terrorism agents, in order to distinguish between natural
outbreaks and/or intentional release of micro-organisms,
and to help trace back the origin of an aggression. We have
here evaluated the Agilent 2100 "Lab on a Chip" platform
for genotyping of B. anthracis and Y. pestis strains on. This
assay runs in 30 minutes one 12 multiplexed PCR reac-
tions chip, genotyping a single isolate at a time. For this
reason this system is faster compared to automated
sequencing devices, either slab gel or capillary based when
a single strain has to be genotyped. Given the possibility
to compare different chip runs in different times this
device can immediately show identities or diversities
between new isolates compared to already characterized
ones. Moreover it has shown a high degree of automation
either for amplicon separation or for digital output of
results. Compared to previous genotyping methods, the
Bionalyzer is more effective than standard ethidium bro-
mide slab gel electrophoresis, giving reproducible, precise
and more sensible output for the shortest repeat units.
Since no fluorescent primers are required the assay is
cheaper to maintain than CEQ8000 or other sequencing
machines. A rough estimation of the total cost of a 25 loci
assay indicates that genotyping on this equipment is at
least four to ten times less expensive than a capillary sys-
tem assay, at low to medium throughput level. The equip-
ment itself is cheaper, and both consumables and
equipment can be stored for a long period of time and
activated when needed.
Finally, the results are comparable to those obtained by
automated sequencers. This platform appears particularly
useful when response time is the critical factor. We pro-
pose therefore such a system as a method suitable for high
resolution identification of biothreat agents. To date this
system is the most effective genotyping technology availa-
35 984 912 72
9 ypms71 (0.2) 14 5 157 163 -6
6 171 178 -7
ypms46 (0.2) 7 3 238 243 -5
4 245 250 -5
5 252 256 -4
6 259 263 -4
10 308 313 -5
12 322 326 -4
10 ypms70 (0.2) 9 5 137 145 -8
6 146 155 -9
8 164 174 -10
9 173 185 -12
11 191 205 -14
ypms54 (0.2) 22 6 259 265 -6
7 281 289 -8
11 ypms69 (0.2) 16 5 163 164 -1
6 179 177 2
7 195 195 0
ypms06 (0.2) 60 3 306 309 -3
4 366 374 -8
6 486 504 -18
8 606 625 -19
9 666 674 -8
12 ypms73 (0.2) 18 5 207 212 -5
6 225 231 -6
ypms21* (0.2) 18 9 329 339 -10
10 347 358 -11
11 365 375 -10
* modified primer set (increased final fragment size)
Table 2: Comparison between Y. pestis product sizes inferred by Agilent 2100 Bioanalyzer software (OBSERVED SIZE) and actual sizes 
obtained by direct sequencing of the PCR product or data available in Genbank (EXPECTED SIZE). UL BPS (unit length size). Page 8 of 11
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used for fast quality-checking of type collection, and DNA
preparations for biosecurity and strain accountability pur-
poses. Typing data produced by the MLVA approach can
be easily compared using shared internet databases, as
illustrated for instance in [18].
Conclusion
In this paper we describe a fieldable genotyping method
for B. anthracis and Y. pestis. This method is an adaptation
on Agilent 2100 Bioanalyzer of previously described 25
loci MLVA. The system was validated by characterizing
thirty-nine B. anthracis and ten Y. pestis isolates, demon-
strating to be, for a single genotyping, more rapid than tra-
ditional methods. The transfer on a new platform
maintains reproducibility and precision to unambigously
identify alleles. This method is shown to be a valid alter-
native to standard genotyping techniques for field charac-
terization of important biothreat agents.
Methods
Bacterial strains and isolates
The strains and DNA samples genotyped for this report are
from the collection maintained by the French Ministry of
Defence at Centre d'Etude du Bouchet (CEB), from Isti-
tuto Superiore di Sanità (ISS) Italian collections and from
the Italian Reference Center for Anthrax (ISZ, Foggia)
[16].
Table 3: Modified primers for Y. pestis from [15] designed for the 
new multiplexed reactions.
YP MODIFIED 
MARKERS
PRIMER SEQUENCE
YPms01 F: ACTTCGATGATTATTTTGTGCGTA
R: TGTTTGGTGCTATTGCCGTA
YPms09 F: TTTTTGCCGCACTGAACATA
R: TCTGATGATTGTTGTGGTCGT
YPms15 F: ACAAGCAAGTTGCGCAGATA
R: CAAGTTCGCTTTCTGTGTCG
YPms20 F: GCCAGAATAATGGCCGTAAA
R: GTGGTTGTTCTTCACGTTGC
Ypms21 F: ACCGGCTTAAAGCAGATTGA
R: TTCCCTGTACTCGATTGTTGTG
YPms40 F: TCCTGCTGCTGAGTTCATCTT
R: TCATGTGCAATAGGCGTTGT
YPms56 F: GCTCTAACAACGCCGGTAAA
R: ATGGCATCAACCGACTGACT
YPms62 F: AAACGGTCGTTAACGGAAGA
R: GCTGAACAGCCCCATAAAAC
Multiplex n. 2 electropherogram comparison between three different B. anthracis strains (depicted in red, blue and green)Figure 3
Multiplex n. 2 electropherogram comparison between three different B. anthracis strains (depicted in red, blue and green). For 
every amplicon the observed size and, in bold, the corresponding allele enumeration of markers vrrB2 BAMS5, and BAMS15 
are shown.
 




	

	








	










Page 9 of 11
(page number not for citation purposes)
BMC Microbiology 2008, 8:21 http://www.biomedcentral.com/1471-2180/8/21VNTR amplification and analysis
DNA purification was performed as reported elsewhere
[15,19]. Up to 30 ng of genomic DNA for each PCR reac-
tion were used for DNA amplification in a final volume of
15 µl containing: 1× PCR reaction buffer (10 mM Tris-
HCl, 1,5 mM MgCl2, 50 mM Kcl pH 8.3), 0.2 mM dNTPs,
1 U Taq polymerase and the appropriate concentrations
of each primer as reported in Marker columns Table 1 and
2. PCR amplifications were conducted on a Peltier Ther-
mal Cycler DNA Engine DYAD (MJ Research) as follow:
initial denaturation step at 96°C for 3 min, 36 cycles of
denaturation at 95°C for 20 seconds, annealing at 60°C
for 30 seconds and extension at 72°C for 2 min. The reac-
tions were terminated by a final incubation at 72°C for 5
min. Each reaction was loaded into chip wells prepared
according to manufacturer recommendations (DNA 1000
LabChip Kit). Each chip contains 16 wells, 12 for the sam-
ples, 3 for gel mix (1 labeled black G and 2 grey G) and 1
for the ladder. Briefly, the black G well of DNA LabChip
support was filled with 9 µl of a gel containing intercalat-
ing dye. The DNA LabChip was pressurized by a syringe in
a priming station device and released after 60 sec. Then,
two grey G wells were filled with 9 µl of gel-dye mix. After
gel preparation, each sample well was loaded with 1 µl of
PCR reaction and 5 µl of internal marker (containing two
MW size standards of 15 and 1500 bp). Finally 1 µl of
DNA ladder was loaded in the ladder well, the chip vor-
texed for 60 sec and inserted into Agilent 2100 Bioana-
lyzer. During the run the instrument analyzed
sequentially every sample, showing electropherogram,
virtual gel image and table data.
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